FASLG and autoimmune polyendocrinopathy: The Sydney classification included the addition of anti-β2 glycoprotein-I antibodies (anti-β 2GPI) among the laboratory criteria, which were not considered in the previous classification, and a subclassification of APS in four different subgroups, according to different aPL positivity combinations [16].